fda approved semaglutide for weight loss FDA-Approved Oral Semaglutide: The First GLP-1 Pill New Weight Loss Medication Wegovy™

People currently using the 2.4mg weekly Wegovy injection may be able to switch directly to the 25mg daily tablet, subject to clinical assessment by our prescriber

Meta-analysis in clinical trials

Expert insight from our panelists: Morgan Lee, PhD, MPH, CPH Vice President, Research & Marketing Scott Halperin, PharmD Vice President, Employer Pharmacy Benefit Consulting Steve Altenburger, PharmD Senior Pharmacy Benefit Consultant

The most common side effects of GLP-1s are gastrointestinal, such as nausea, vomiting, and constipation

So far, no specific menstrual or reproductive issue has been identified as a common side effect of these drugs

PubMed laboratory research record [PMID: 40511027] PubMed record related to this compound for laboratory literature review